These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9607860)

  • 1. Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy.
    Nielsen SD; Afzelius P; Dam-Larsen S; Nielsen C; Nielsen JO; Mathiesen L; Hansen JE
    J Infect Dis; 1998 Jun; 177(6):1733-6. PubMed ID: 9607860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals.
    Law P; Lane TA; Gervaix A; Looney D; Schwarz L; Young D; Ramos S; Wong-Staal F; Recktenwald D; Ho AD
    Exp Hematol; 1999 Jan; 27(1):147-54. PubMed ID: 9923453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals.
    Nielsen SD; Sørensen TU; Aladdin H; Ersbøll AK; Mathiesen L; Ullum H; Gerstoft J; Nielsen JO; Pedersen BK
    Scand J Immunol; 2000 Sep; 52(3):298-303. PubMed ID: 10972907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy.
    Baillou C; Simon A; Leclercq V; Azar N; Rosenzwajg M; Herson S; Klatzmann D; Lemoine FM
    AIDS; 2003 Mar; 17(4):563-74. PubMed ID: 12598777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients.
    Dam Nielsen S; Kjaer Ersboll A; Mathiesen L; Nielsen JO; Hansen JE
    J Infect Dis; 1998 Nov; 178(5):1299-305. PubMed ID: 9780249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons.
    Nielsen SD; Clark DR; Hutchings M; Dam-Larsen S; Repping S; Nielsen JO; Mathiesen L; Miedema F; Hansen JE
    J Infect Dis; 1999 Dec; 180(6):1819-26. PubMed ID: 10558936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults.
    Slobod KS; Bennett TA; Freiden PJ; Kechli AM; Howlett N; Flynn PM; Head DR; Srivastava DK; Boyett JM; Brenner MK; Garcia JV
    Blood; 1996 Nov; 88(9):3329-35. PubMed ID: 8896397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team.
    Campbell TB; Sevin A; Coombs RW; Peterson GC; Rosandich M; Kuritzkes DR; Mladenovic J; Landay A; Wong R; Ambruso D; Miles S; Pomerantz RJ; Schooley RT
    Blood; 2000 Jan; 95(1):48-55. PubMed ID: 10607683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.
    Aladdin H; Ullum H; Dam Nielsen S; Espersen C; Mathiesen L; Katzenstein TL; Gerstoft J; Skinhoj P; Pedersen BK
    J Infect Dis; 2000 Mar; 181(3):1148-52. PubMed ID: 10720544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART.
    Aladdin H; Ullum H; Katzenstein T; Gerstoft J; Skinhøj P; Klarlund Pedersen B
    Scand J Immunol; 2000 May; 51(5):520-5. PubMed ID: 10792845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease.
    Schooley RT; Mladenovic J; Sevin A; Chiu S; Miles SA; Pomerantz RJ; Campbell TB; Bell D; Ambruso D; Wong R; Landay A; Coombs RW; Fox L; Kamoun M; Jacovini J
    J Infect Dis; 2000 Jan; 181(1):148-57. PubMed ID: 10608761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.
    Silvestri G; Munoz-Calleja C; Bagnarelli P; Piedimonte G; Clementi M; Montroni M
    Clin Exp Immunol; 1998 Jan; 111(1):3-11. PubMed ID: 9472655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human granulocyte colony-stimulating factor increases circulating CD34-postive cells in patients with AIDS.
    Nielsen SD; Dam-Larsen S; Nielsen C; Wantzia P; Mathiesen L; Hansen JE
    Ann Hematol; 1997 May; 74(5):215-20. PubMed ID: 9200993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals.
    Gervaix A; Schwarz L; Law P; Ho AD; Looney D; Lane T; Wong-Staal F
    Hum Gene Ther; 1997 Dec; 8(18):2229-38. PubMed ID: 9449376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset.
    Aukrust P; Svardal AM; Müller F; Lunden B; Nordøy I; Frøland SS
    Blood; 1996 Oct; 88(7):2626-33. PubMed ID: 8839856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.
    Fadul N; Couturier J; Yu X; Kozinetz C; Arduino R; Lewis DE
    South Med J; 2017 Nov; 110(11):709-713. PubMed ID: 29100221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.